The National Awareness and Early Diagnosis Initiative in England: assembling the evidence

M A Richards, M A Richards

Abstract

A National Awareness and Early Diagnosis Initiative (NAEDI) has been established in England as part of the Government's strategy to improve cancer outcomes. One of the early priorities for this initiative has been to assemble the diverse evidence linking late diagnosis with poor survival and avoidable deaths. This supplement brings together new perspectives on existing research in this area together with findings from recently commissioned research. This paper describes a provisional model, the 'NAEDI pathway', for testing hypotheses relating to late diagnosis and its impact. Key findings from other papers in this supplement are also highlighted.

Figures

Figure 1
Figure 1
The NAEDI pathway.

References

    1. Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009) What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 101(Suppl 2): S115– S124
    1. Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M (1994) Patient's and doctor's delay in primary breast cancer. Acta Oncol 33: 345–351
    1. Austoker J, Bankhead C, Forbes LJL, Atkins L, Martin F, Robb K, Wardle J, Ramirez AJ (2009) Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer 101(Suppl 2): S31– S39
    1. Baughan P, O'Neill B, Fletcher E (2009) Auditing the diagnosis of cancer in primary care: the experience in Scotland. Br J Cancer 101(Suppl 2): S87– S91
    1. Berrino F, De AR, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaguilani M and the EUROCARE Working Group (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE 4 study. Lancet Oncol 8: 773–783
    1. Coleman MP, Babb P, Sloggett A, Quinn M, De Stavola B (2001) Socioeconomic inequalities in cancer survival in England and Wales. Cancer 91(Suppl 1): 208–216
    1. Department of Health (2007) Cancer Reform Strategy. Department of Health: London, England
    1. Eadie D, MacKintosh AM, MacAskill S, Brown A (2009) Development and evaluation of an early detection intervention for mouth cancer using a mass media approach. Br J Cancer 101(Suppl 2): S73– S79
    1. Eilbert KW, Carroll K, Peach J, Khatoon S, Basnett I, McCulloch N (2009) Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets. Br J Cancer 101(Suppl 2): S64–S67
    1. Hamilton W (2009) The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer 101(Suppl 2): S80–S86
    1. Jack RH, Davies EA, Møller H (2009) Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer 100: 545–550
    1. Linsell L, Forbes LJL, Kapari M, Burgess C, Omer L, Tucker L, Ramirez AJ (2009) A randomised controlled trial of an intervention to promote early presentation of breast cancer in older women: effect on breast cancer awareness. Br J Cancer 101(Suppl 2): S40–S48
    1. Lyon D, Knowles J, Slater B, Kennedy R (2009) Improving the early presentation of cancer symptoms in disadvantaged communities: putting local people in control. Br J Cancer 101(Suppl 2): S49–S54
    1. Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ (2009) Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer 101(Suppl 2): S92–S101
    1. Møller H, Linklater KM, Robinson D (2009) A visual summary of the EUROCARE-4 results: a UK perspective. Br J Cancer 101(Suppl 2): S110–S114
    1. Neal RD (2009) Do diagnostic delays in cancer matter? Br J Cancer 101(Suppl 2): S9–S12
    1. Nunn H, Lalli A, Fortune F, Croucher R (2009) Oral cancer screening in the Bangladeshi community of Tower Hamlets: a social model. Br J Cancer 101(Suppl 2): S68–S72
    1. Olesen F, Hansen RP, Vedsted P (2009) Delay in diagnosis: the experience in Denmark. Br J Cancer 101(Suppl 2): S5–S8
    1. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA (1999) Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 353: 1127–1131
    1. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ (1999) Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 353: 1119–1126
    1. Richards MA (2009) The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 101(Suppl 2): S125–S129
    1. Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Waller J, Hiom S, Wardle J (2009) Public awareness of cancer in Britain: a population-based survey of adults. Br J Cancer 101(Suppl 2): S18–S23
    1. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F, and the EUROCARE working group (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106: 416–422
    1. Sant M, Allemani C, Santaquilani M, Knign A, Marchesi F, Capocaccia R (2009) EUROCARE 4 Survival of cancer patients diagnosed in 1995–1999 Results and commentary. Eur J Cancer 45: 931–991
    1. Stubbings S, Robb K, Waller J, Ramirez A, Austoker J, Macleod U, Hiom S, Wardle J (2009) Development of a measurement tool to assess public awareness of cancer. Br J Cancer 101(Suppl 2): S13–S17
    1. Thomson CS, Forman D (2009) Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer 101(Suppl 2): S102–S109
    1. von Wagner C, Good A, Wright D, Rachet B, Obichere A, Bloom S, Wardle J (2009) Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer 101(Suppl 2): S60–S63
    1. Waller J, Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Hiom S, Wardle J (2009) Awareness of cancer symptoms and anticipated help seeking among ethnic minority groups in England. Br J Cancer 101(Suppl 2): S24–S30
    1. Weller DP, Campbell C (2009) Uptake in cancer screening programmes: a priority in cancer control. Br J Cancer 101(Suppl 2): S55–S59

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi